Presentation TCT 2014 Heart Team Decisions: Who Is the Appropriate Prohibitive-Risk DMR Patient for MitraClip? Presenter: Gorav Ailawadi September 13, 2014 REGISTER for free or LOG IN to view this content Mitral Valve Presentation TCT 2014 Up Next Presentation TCT 2014 Setting the Stage: Most Important Mitral Regurgitation Studies and Events of the Last 12 Months Presenter: Gregg W. Stone September 13, 2014 More slides + Presentation TCT 2014 RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents Presenter: Fernando Alfonso September 14, 2014 Presentation TCT 2014 Natural History of Vulnerable Plaque: Targets for Risk Stratification Presenter: Peter H. Stone September 14, 2014 We Recommend
Presentation TCT 2014 Setting the Stage: Most Important Mitral Regurgitation Studies and Events of the Last 12 Months Presenter: Gregg W. Stone September 13, 2014
Presentation TCT 2014 RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents Presenter: Fernando Alfonso September 14, 2014
Presentation TCT 2014 Natural History of Vulnerable Plaque: Targets for Risk Stratification Presenter: Peter H. Stone September 14, 2014